FDA Approves Philips Scanners
In the face of high competition, the Dutch company Royal Philips Electronics NV (NYSE:PHG) got approval from the U.S. Food and Drug Administration (FDA) to sell a combination scanner that performs both positron emission tomography (PET) and magnetic resonance imaging. The scanner is expected to accelerate imaging time for cancer patients, as PET identifies cancer [...]
In the face of high competition, the Dutch company Royal Philips Electronics NV (NYSE:PHG) got approval from the U.S. Food and Drug Administration (FDA) to sell a combination scanner that performs both positron emission tomography (PET) and magnetic resonance imaging. The scanner is expected to accelerate imaging time for cancer patients, as PET identifies cancer cells as it absorbs chemical tracers.
The magnetic resonance imaging will be helpful to identify the surrounding tissue. In addition, … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards